Eubiotics Market Research and Forecast Report 2024-2032
                     Global Eubiotics Market 
Research and Forecast 
Report 2024-2032
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved 
About IMARC Group
In ternat ional  Market  Analys is  Research and Consul t ing Group is  a leading adv iser  on management  
s t rategy and market  research wor ldwide.  We par tner  wi th c l ients  in  a l l  regions and indust ry  
vert ica ls  to  ident i fy  thei r  h ighest -value oppor tuni t ies,  address thei r  most  cr i t ica l  chal lenges,  and 
t ransform thei r  bus inesses.
IMARC’s in format ion products  inc lude major market ,  sc ient i f ic ,  economic and technological  
developments  for  bus iness leaders  in  pharmaceut ica l ,  indust r ia l ,  and h igh technology 
organizat ions.  Market  forecasts  and indust ry  analys is  for  b iotechnology,  advanced mater ia ls ,  
chemicals ,  food and beverage,  t ravel  and tour ism, nanotechnology and novel  process ing methods 
are at  the top of  the company’s  exper t ise.
IMARC’s ta i lored approach combines unfathomable ins ight  in to the dynamics o f  companies and 
markets wi th c lose cooperat ion at  a l l  levels  of  the c l ient  organizat ion.  This ensures that  our  c l ients 
achieve unmatchable compet i t ive advantage,  bui ld  more pro f ic ient  organizat ions,  and secure 
las t ing resul ts .
Accord ing  t o  t he  la tes t  repo r t  by  IMARC Group ,  t i t l ed  "Eub io t i cs  M arket :  G l oba l  
Indust ry  T rends ,  Share ,  S ize ,  G rowth ,  Opportun i ty  and  Forecast  2024-
2032, "  t he  g loba l  eub io t i cs  marke t  s i ze  reached  US$ 4 .6  B i l l i on  in  2023 .
Eub io t i cs  a re  innova t i ve  feed  add i t i ves  t ha t  suppor t  an ima l  pe r f o rmance and 
Report wel f a re  by  p rom ot ing  gu t  hea l th .  Some commonly  used  eub io t i cs  inc lude  o rgan i c  ac ids ,  p rob io t i cs ,  p reb io t i cs ,  phy togen ics  o r  essen t i a l  o i l s ,  and  gu t  hea l th  
enzymes .  They  ac t  as  na tu ra l  d iges t i ve  s t imu lan t s  and  ass is t  i n  enhanc ing  
Highlight and d iges t i ve  hea l th ,  nu t r ien t  absorp t ion ,  and  s t r engt hen ing  immun i t y  i n  pou l t r y ,  
sw ine ,  l i ves tock ,  and  aqua t i c  an ima ls .  
Description They  a id  i n  ma in ta in ing  a  hea l t hy  ba lance  o f  m ic rob io ta  in  t he  gas t ro in t es t i na l  t r ac t  such  as  bac te r i a ,  a r chaea ,  p ro t i s t s ,  and  fung i .  They  a lso  p lay  an  essen t ia l  
ro le  in  im muno log ic ,  ho rmona l ,  and  me tabo l i c  homeos tas i s .  As  a  resu l t ,  eub io t i cs  
a re  ga in ing  immense  t rac t ion  as  an  a l t e rna t i ve  to  an t ib io t i cs  in  t he  f eed .
Request  fo r  a  PDF sample  o f  th is  repor t :  
ht tps : / / www. imarcgroup .com/eub io t i cs -marke t / reques t samp le
Report Description
Gl o b a l  E u b io t i c s  M a r ke t  T r en d s :
T he  r a p i d  i n d u s t r i a l i z a t i o n  o f  t h e  l i ve s t o ck  i n d u s t r y  d ue  t o  t h e  e s c a l a t i n g  d em a n d  f o r  po u l t r y  m ea t  a n d  d a i r y  p r o du c t s  
re p r e se n t s  t h e  p r i ma r y  f a c to r  d r i v i n g  t h e  m a r k e t  g r ow t h .  Mo r e o v e r ,  t h e  r i s i ng  c o n c e r n s  r eg a r d i n g  m e a t  q ua l i t y  a mo n g  
co n s u me r s  i s  a n o t h e r  ma j o r  g r o w th - i n d u c i n g  f a c t o r .  B e s i d e s  t h i s ,  t h e  g r ow i n g  p r ev a l e n c e  o f  l i v e s t o ck  d i s e a se s  h a s  
s t r e n g th e n e d  t h e  p r o du c t  d em a n d  a s  c o n s u mp t i o n  o f  e u b i o t i c s - b a s e d  f e ed  p ro v i d e s  e ss e n t i a l  n u t r i e n t s  a n d  h ea l t h  a n d  
me d i c i n a l  b e n e f i t s  t o  l i v e s t oc k ,  s u ch  a s  p r e v en t i o n  an d  t i me l y  t r e a t m en t  o f  c h r o n i c  d i s e as e s .  
A d d i t i o na l l y ,  t h e r e  h a s  b e e n  a  r i s e  i n  t h e  u sa g e  o f  eu b i o t i c s  a s  a  su b s t i t u t e  f o r  an t i b i o t i c  g r ow t h  p r o mo t e r s  (A G P s )  i n  a n i m a l s  
an d  l i v es t o c k .  I n  l i ne  w i t h  t h i s ,  t h e  i n c r ea s i n g  d om e s t i c a t i o n  o f  an i m a l s  a s  pe t s ,  e s p e c i a l l y  i n  de v e l o pe d  n a t i o n s ,  h a s  
ac c e l e ra t e d  th e  p r o d uc t  a d o p t i o n  r a t e .  F u r t h e r mo r e ,  s ev e r a l  k e y  p l a ye r s  a r e  u t i l i z i n g  i n n o v a t i ve  m i c r o b i o l o g i c a l  s o l u t i o n s  t o  
de v e l o p  n o v e l  p r o d u c t  v a r i a n ts  w i th  t a r ge t e d  r es u l t s  an d  e a sy  d i g e s t i b i l i t y .  A l o n g  w i t h  t h i s ,  t h e  i mp l e m en t a t i o n  o f  s t r i ng e n t  
l aw s  a n d  r e gu l a t i o n s  d i s c o u r a g i n g  t h e  u s ag e  o f  an t i b i o t i c s  b y  g o ve r n i n g  a g en c i e s  o f  v a r i o us  c ou n t r i es  h as  p r o p e l l e d  m a rk e t  
g r o w t h .  O t h e r  f a c t o r s ,  i n c l u d i ng  t h e  s u r g i n g  a w a r en e s s  re g a r d i n g  f e e d  q u a l i t y  a n d  sa f e t y ,  s h i f t i n g  c o n s um e r  p re f e r en c e s  
t ow a r d  p ro t e i n - r i c h  d i e t s ,  i n f l a t i n g  p r i c es  o f  na t u r a l  f ee d  g r a d e s ,  an d  t e c h n o l o g i c a l  a dv a n ce m e n ts ,  a r e  a l s o  p r o v i d i n g  a  
po s i t i v e  t h r u s t  t o  t h e  m a r k e t  g r o w t h .
V i e w  R e p o r t  T O C ,  F i g u r e s  a n d  T a b l e s :  h t t p s : / / w ww . i m a r c g ro u p . co m / e u b i o t i cs - m ar k e t
Breakup by Product:
• Probiot ics
• Prebiot ics
• Organic  Ac ids
• Essent ia l  Oi ls
• Others
Report Breakup by Form:
Segmentation • Liquid
• Sol id
Breakup by Application:
• Gut Health
• Immunity
• Yie ld
• Others
Breakup by End-Use:
• Catt le Feed
• Poultry Feed
• Swine Feed
• Aquafeed
• Others
Report 
Segmentation Breakup by Region:
• North America
• Asia-Pacifi c
• Europe
• Latin America
• Middle East and Afr ica
• Advanced Bionutri t ion Corp.
• Behn Meyer Holding AG
• Beneo Gmbh (Südzucker AG)
• Calpis Co. Ltd. (Asahi  Group Holdings Ltd.)
Competitive • Koninkl i jke DSM N.V.
Landscape • DuPont de Nemours Inc.
• Kemin Industries Inc.
with Key 
• Lal lemand Inc.
Players • Lesaff re
• Novus International  Inc. (Mitsui  & Co. Ltd.)
• UAS Laboratories LLC (Chr. Hansen Holding 
A/S).
How has the global eubiotics market performed so 
far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities 
in the global eubiotics market?
What is the impact of each driver, restraint, and 
opportunity on the global eubiotics market?
Key 
What are the key regional markets?
Questions 
Answered in Which countries represent the most attractive eubiotics market?
the Report What is the breakup of the market based on the 
product?
Which is the most attractive product in the 
eubiotics market?
What is the breakup of the market based on the 
form?
Which is the most attractive form in the eubiotics 
market?
What is the breakup of the market based on the 
application?
What is the most attractive application in the 
eubiotics market?
What is the breakup of the market based on the 
end-use?
Key 
Which is the most attractive end-use segment in 
Questions the eubiotics market?
Answered in What is the breakup of the market based on the Region?
the Report Which region represents the most attractive 
eubiotics market?
What is the competitive structure of the market?
Who are the key players/companies in the global 
eubiotics market?
1     P r e f a c e
2     S c o p e  a n d  M e t h o d o l o g y
    2 . 1     O b j e c t i v e s  o f  t h e  S t u d y
    2 . 2     S t a k e h o l d e r s
    2 . 3     D a t a  S o u r c e s
        2 . 3 . 1     P r i m a r y  S o u r c e s
        2 . 3 . 2     S e c o n d a r y  S o u r c e s
    2 . 4     M a r k e t  E s t i m a t i o n
Table of         2 . 4 . 1     B o t t o m - U p  A p p r o a c h        2 . 4 . 2     T o p - D o w n  A p p r o a c h
    2 . 5     F o r e c a s t i n g  M e t h o d o l o g y
3     E x e c u t i v e  S u m m a r y
4     I n t r o d u c t i o n
Contents     4 . 1     O v e r v i e w    4 . 2     K e y  I n d u s t r y  T r e n d s5     G l o b a l  E u b i o t i c s  M a r k e t
    5 . 1     M a r k e t  O v e r v i e w
    5 . 2     M a r k e t  P e r f o r m a n c e
    5 . 3     I m p a c t  o f  C O V I D - 1 9
    5 . 4     M a r k e t  F o r e c a s t
6      M a r k e t  B r e a k u p  b y  P r o d u c t
    6 . 1     P r o b i o t i c s
        6 . 1 . 1  M a r k e t  T r e n d s
        6 . 1 . 2  M a r k e t  F o r e c a s t
    6 . 2     P r e b i o t i c s
        6 . 2 . 1  M a r k e t  T r e n d s
        6 . 2 . 2  M a r k e t  F o r e c a s t
    6 . 3     O r g a n i c  A c i d s
        6 . 3 . 1  M a r k e t  T r e n d s
        6 . 3 . 2  M a r k e t  F o r e c a s t
       
    6 . 4     E s s e n t i a l  O i l s
        6 . 4 . 1  M a r k e t  T r e n d s
        6 . 4 . 2  M a r k e t  F o r e c a s t
    6 . 5     O t h e r s
        6 . 5 . 1  M a r k e t  T r e n d s
        6 . 5 . 2  M a r k e t  F o r e c a s t
7    M a r k e t  B r e a k u p  b y  F o r m
    7 . 1     L i q u i d
        7 . 1 . 1  M a r k e t  T r e n d s
        7 . 1 . 2  M a r k e t  F o r e c a s t
    7 . 2     S o l i d
Table of         7 . 2 . 1  M a r k e t  T r e n d s
        7 . 2 . 2  M a r k e t  F o r e c a s t
8    M a r k e t  B r e a k u p  b y  A p p l i c a t i o n
Contents     8 . 1     G u t  H e a l t h        8 . 1 . 1  M a r k e t  T r e n d s
        8 . 1 . 2  M a r k e t  F o r e c a s t
    8 . 2     I m m u n i t y
        8 . 2 . 1  M a r k e t  T r e n d s
        8 . 2 . 2  M a r k e t  F o r e c a s t
    8 . 3     Y i e l d
        8 . 3 . 1  M a r k e t  T r e n d s
        8 . 3 . 2  M a r k e t  F o r e c a s t
    8 . 4     O t h e r s
        8 . 4 . 1  M a r k e t  T r e n d s
        8 . 4 . 2  M a r k e t  F o r e c a s t
9    M a r k e t  B r e a k u p  b y  E n d  U s e
    9 . 1     C a t t l e  F e e d
        9 . 1 . 1  M a r k e t  T r e n d s     
F o r  m o r e  i n f o r m a t i o n ,  v i s i t :  
h t t p s : / / w w w. im a rcg ro u p . co m / e u b i o t i c s - m a r ke t / t o c
Partial List of Clients
Partial List of Clients
Disclaimer
© 2024  IMARC Al l  R ights  Reserved 
Th is  Pub l i ca t ion  and  a l l  i t ’ s  con ten ts  un less  o therw ise  men t i oned  a re  copy r i gh ted  in  the  name o f  
I n t e rna t i ona l  Marke t  Ana lys i s  Research  and  Consu l t ing  ( IMARC) .  No  pa r t  o f  t h i s  pub l i ca t ion  may  be  
rep roduced ,  repackaged ,  red i s t r i bu ted  o r  res o ld  i n  who le  o r  i n  any  pa r t .  The  pub l i ca t ion  may  a l so  
no t  be  used  i n  any  f o rm o r  by  and means  g raph i c  e lec t ron ic  o r  mechan ic a l ,  i nc lud ing  pho tocopy ing ,  
reco rd ing ,  t ap ing  o r  by  i n fo rmat i on  s to rage  o r  re t r ieva l ,  o r  by  any  o the r  f o rm,  w i t hou t  the  exp ress  
c ons en t  o f  I n t e rna t iona l  Marke t  Ana lys i s  Research  and  Consu l t i ng  ( IMARC) .
Disc la imer :  Al l  con ten ts  and  da ta  o f  t h i s  pub l i c a t i on ,  i nc lud ing  fo recas t s ,  da ta  ana lys i s  and  op in ion  
have  been  based  on  in f o rmat ion  and  sources  be l ieved  to  be  accu ra te  and  re l iab le  a t  t he  t ime  o f  
pub l i sh ing .  In t e rna t i ona l  Ma rke t  Ana l ys is  Research  and  Consu l t ing  makes  no  rep resen ta t ion  o f  
war ran t y  o f  any  k ind  as  to  t he  acc u racy  o r  comp le teness  o f  any  I n fo rmat i on  p rov ided .  IMARC 
accep ts  no  l i ab i l i t y  wha tsoever  f o r  any  los s  o r  damage  resu l t i ng  f rom op in ion ,  e r ro rs  o r  
i naccu rac ies  i f  any  f ound  th is  pub l i ca t ion .
IMARC,  IMARC Group  and  G loba l  Therapy  I ns igh t  Ser i es  a re  reg is t e red  t rademarks  o f  I n te rna t iona l  
Marke t  Ana lys i s  Research  and  Consu l t ing .  A l l  o the r  t rademarks  used  i n  th i s  pub l i ca t i on  a re  
reg i s te red  t rademarks  o f  t he i r  r espec t i ve  compan ies .
Contact Us
Visit us at :
https://www.imarcgroup.com
+1-631-791-1145
[email protected]
Stay With Us: